There is a serious shortage of a drug used to treat bladder cancer, reports the Globe and Mail. Without the drug called BCG, some patients may have to have their bladders surgically removed.
Manufacturing problems at two different plants are at the heart of the problem. Doctors are having to ration the drug and are afraid they may run out entirely.
A shortage of drugs to treat cancer is not a new problem in Canada. The Globe reports that reasons involve a scarcity of raw materials, changing rules and consolidation in the pharmaceutical industry.
For reasons beyond our control, and for an undetermined period of time, our comment section is now closed. However, our social networks remain open to your contributions.